Arbor Pharmaceuticals, Inc.

Quick facts

Marketed products

• AR11 · Other
• BiDil XR · Cardiovascular
  BiDil XR combines isosorbide dinitrate and hydralazine to enhance vasodilation and reduce cardiac workload, specifically benefiting patients with heart failure.

Phase 3 pipeline

• Azilsartan Medoxomil Low-dose · Cardiovascular
  Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) that selectively blocks AT1 receptors to reduce blood pressure.
• Glycerin ear drops · Otolaryngology
  Glycerin ear drops work by drawing fluid out of the middle ear through osmotic action, reducing pressure and relieving ear discomfort.
• Placebo for Azilsartan Medoxomil · Cardiovascular
  This is a placebo control with no active pharmacological mechanism.

Phase 1 pipeline

• AR10

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Arbor Pharmaceuticals, Inc. portfolio CI brief
• Arbor Pharmaceuticals, Inc. pipeline updates RSS